9 Articles
9 Articles

Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty
By Julie Steenhuysen and Deena Beasley
Death Sentence: The real cost of Trump’s aid cuts on HIV
In his first hours as US president, Donald Trump signed an order freezing most foreign aid for 90 days — this included funding to PEPFAR, the global HIV programme credited with saving millions of lives. Although a waiver was later issued, experts say the fallout has been fatal. The Independent’s Bel Trew travelled to Uganda and Zimbabwe, where people are dying because they can’t access medication and pregnant women fear infecting their babies. T…
Gilead Sciences Plans to Supply Twice-Yearly HIV Prevention Shot to Low-Income Countries Pending FDA Approval
Gilead Sciences plans to continue supplying its twice-y […] The post Gilead Sciences Plans to Supply Twice-Yearly HIV Prevention Shot to Low-Income Countries Pending FDA Approval first appeared on GeneOnline News. The post Gilead Sciences Plans to Supply Twice-Yearly HIV Prevention Shot to Low-Income Countries Pending FDA Approval appeared first on GeneOnline News.
DAILY DOSE: Trump is destroying efforts to combat HIV/AIDS in Africa; Pharma company crashes after gene therapy patient dies. - Scientific Inquirer
U.S. aid helped two African countries rein in HIV. Then came Trump The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has been instrumental in combating HIV/AIDS in Africa, initiating treatment for 21 million people and saving 26 million lives. However, the Trump administration’s significant cuts to foreign aid have jeopardized these achievements, leading to concerns about the resurgence of HIV/AIDS in affected regions. The reduction i…
Coverage Details
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage